T. Rowe Price Associates’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $300K | Buy |
|
|||||
|
2025
Q2 | $117K | Buy |
|
|||||
|
2025
Q1 | $51K | Hold |
|
|||||
|
2024
Q4 | $56K | Sell |
|
|||||
|
2024
Q3 | $222K | Buy |
|
|||||
|
2024
Q2 | $245K | Buy |
|
|||||
|
2024
Q1 | $369K | Buy |
|
|||||
|
2023
Q4 | $431K | Sell |
|
|||||
|
2023
Q3 | $342K | Buy |
|
|||||
|
2023
Q2 | $294K | Buy |
|
|||||
|
2023
Q1 | $255K | Buy |
|
|||||
|
2022
Q4 | $268K | Sell |
|
|||||
|
2022
Q3 | $424K | Buy |
|
|||||
|
2022
Q2 | $364K | Buy |
|
|||||
|
2022
Q1 | $476K | Buy |
|
|||||
|
2021
Q4 | $626K | Sell |
|
|||||
|
2021
Q3 | $1.76M | Buy |
|
|||||
|
2021
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q1 | $1.34M | Buy |
|
|||||
|
2020
Q4 | $1.89M | Buy |
|
|||||
|
2020
Q3 | $415K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $7.04M | Sell |
|
|||||
|
2018
Q4 | $11.9M | Sell |
|
|||||
|
2018
Q3 | $24.6M | Sell |
|
|||||
|
2018
Q2 | $28.1M | Sell |
|
|||||
|
2018
Q1 | $29.6M | Sell |
|
|||||
|
2017
Q4 | $27.6M | Sell |
|
|||||
|
2017
Q3 | $29.7M | Sell |
|
|||||
|
2017
Q2 | $24.5M | Buy |
|
|||||
|
2017
Q1 | $31.3M | Sell |
|
|||||
|
2016
Q4 | $26.5M | Sell |
|
|||||
|
2016
Q3 | $25.3M | Buy |
|
|||||
|
2016
Q2 | $33.5M | Buy |
|
|||||
|
2016
Q1 | $47.2M | Buy |
|